table of content
1 Study Coverage
1.1 Hepatitis B Vaccine (Recombinant) Product Introduction
1.2 Market by Type
1.2.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 10mcg/0.5ml
1.2.3 10mcg/ml
1.3 Market by Application
1.3.1 Global Hepatitis B Vaccine (Recombinant) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Newborn
1.3.3 Adult
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hepatitis B Vaccine (Recombinant) Sales Estimates and Forecasts 2017-2028
2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Estimates and Forecasts 2017-2028
2.3 Global Hepatitis B Vaccine (Recombinant) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hepatitis B Vaccine (Recombinant) Sales by Region
2.4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022)
2.4.2 Global Sales Hepatitis B Vaccine (Recombinant) by Region (2023-2028)
2.5 Global Hepatitis B Vaccine (Recombinant) Revenue by Region
2.5.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022)
2.5.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hepatitis B Vaccine (Recombinant) Sales by Manufacturers
3.1.1 Global Top Hepatitis B Vaccine (Recombinant) Manufacturers by Sales (2017-2022)
3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hepatitis B Vaccine (Recombinant) in 2021
3.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers
3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Manufacturers (2017-2022)
3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hepatitis B Vaccine (Recombinant) Revenue in 2021
3.3 Global Hepatitis B Vaccine (Recombinant) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hepatitis B Vaccine (Recombinant) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hepatitis B Vaccine (Recombinant) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hepatitis B Vaccine (Recombinant) Sales by Type
4.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Type (2017-2022)
4.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Type (2023-2028)
4.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2028)
4.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Type
4.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Type (2017-2022)
4.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2028)
4.3 Global Hepatitis B Vaccine (Recombinant) Price by Type
4.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Type (2017-2022)
4.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hepatitis B Vaccine (Recombinant) Sales by Application
5.1.1 Global Hepatitis B Vaccine (Recombinant) Historical Sales by Application (2017-2022)
5.1.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Sales by Application (2023-2028)
5.1.3 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2028)
5.2 Global Hepatitis B Vaccine (Recombinant) Revenue by Application
5.2.1 Global Hepatitis B Vaccine (Recombinant) Historical Revenue by Application (2017-2022)
5.2.2 Global Hepatitis B Vaccine (Recombinant) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2017-2028)
5.3 Global Hepatitis B Vaccine (Recombinant) Price by Application
5.3.1 Global Hepatitis B Vaccine (Recombinant) Price by Application (2017-2022)
5.3.2 Global Hepatitis B Vaccine (Recombinant) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hepatitis B Vaccine (Recombinant) Market Size by Type
6.1.1 North America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
6.1.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
6.2 North America Hepatitis B Vaccine (Recombinant) Market Size by Application
6.2.1 North America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
6.2.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
6.3 North America Hepatitis B Vaccine (Recombinant) Market Size by Country
6.3.1 North America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
6.3.2 North America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hepatitis B Vaccine (Recombinant) Market Size by Type
7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
7.2 Europe Hepatitis B Vaccine (Recombinant) Market Size by Application
7.2.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
7.2.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
7.3 Europe Hepatitis B Vaccine (Recombinant) Market Size by Country
7.3.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
7.3.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Type
8.1.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
8.1.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
8.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Application
8.2.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
8.2.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
8.3 Asia Pacific Hepatitis B Vaccine (Recombinant) Market Size by Region
8.3.1 Asia Pacific Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2028)
8.3.2 Asia Pacific Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Type
9.1.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
9.1.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
9.2 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Application
9.2.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
9.2.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
9.3 Latin America Hepatitis B Vaccine (Recombinant) Market Size by Country
9.3.1 Latin America Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
9.3.2 Latin America Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Type
10.1.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2028)
10.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Application
10.2.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2028)
10.3 Middle East and Africa Hepatitis B Vaccine (Recombinant) Market Size by Country
10.3.1 Middle East and Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Corporation Information
11.3.2 Sanofi Pasteur Overview
11.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Pasteur Recent Developments
11.4 Dynavax Technologies
11.4.1 Dynavax Technologies Corporation Information
11.4.2 Dynavax Technologies Overview
11.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dynavax Technologies Recent Developments
11.5 LG Life Sciences
11.5.1 LG Life Sciences Corporation Information
11.5.2 LG Life Sciences Overview
11.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 LG Life Sciences Recent Developments
11.6 KM Biologics
11.6.1 KM Biologics Corporation Information
11.6.2 KM Biologics Overview
11.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 KM Biologics Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 KM Biologics Recent Developments
11.7 Shenzhen Kangtai Biological Products
11.7.1 Shenzhen Kangtai Biological Products Corporation Information
11.7.2 Shenzhen Kangtai Biological Products Overview
11.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shenzhen Kangtai Biological Products Recent Developments
11.8 Serum Institute
11.8.1 Serum Institute Corporation Information
11.8.2 Serum Institute Overview
11.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Serum Institute Hepatitis B Vaccine (Recombinant) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Serum Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hepatitis B Vaccine (Recombinant) Industry Chain Analysis
12.2 Hepatitis B Vaccine (Recombinant) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hepatitis B Vaccine (Recombinant) Production Mode & Process
12.4 Hepatitis B Vaccine (Recombinant) Sales and Marketing
12.4.1 Hepatitis B Vaccine (Recombinant) Sales Channels
12.4.2 Hepatitis B Vaccine (Recombinant) Distributors
12.5 Hepatitis B Vaccine (Recombinant) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hepatitis B Vaccine (Recombinant) Industry Trends
13.2 Hepatitis B Vaccine (Recombinant) Market Drivers
13.3 Hepatitis B Vaccine (Recombinant) Market Challenges
13.4 Hepatitis B Vaccine (Recombinant) Market Restraints
14 Key Findings in The Global Hepatitis B Vaccine (Recombinant) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
